Fecal DNA Methylation and Helicobacter Pylori Gastric Cancer Susceptibility Genes Test

N/ANot Yet RecruitingNCT06943768

Fudan University9,654 enrolled

Overview

This is a multicenter, cross-sectional study. It is based on fecal methylation site detection, H. pylori susceptibility testing of fecal samples, and a combination of the two, compared with the "gold standard" imaging tests, CT, gastroscopy and/or pathology, for gastric cancer, benign diseases such as gastritis, and health check-ups.

Primary study objective: to evaluate the sensitivity and specificity of fecal methylation site-based and fecal Helicobacter pylori gastric cancer susceptibility gene assays applied to early diagnosis and screening of gastric cancer. Secondary research objectives: 1. the accuracy, kappa value, area under the ROC curve, positive likelihood ratio, negative likelihood ratio, positive predictive value, and negative predictive value of fecal methylation site-based testing and fecal Helicobacter pylori gastric cancer susceptibility gene-based testing applied for predicting gastric cancer; 2. whether the predictive ability is significantly higher than that of conventional tumor markers, such as CA19-9, CEA, and CA72-4; and 3. the follow up of Gastritis and healthy people, to assess the cases of gastric cancer during the follow-up period and the clinical diagnosis and treatment prediction; 4. Follow-up gastric cancer patients, to assess the association with gastric cancer recurrence metastasis and treatment.

Study Type

OBSERVATIONAL

Enrollment

9,654

Conditions

Gastric (Stomach) Cancer

Interventions

fecal methylation site-based testing and fecal Helicobacter pylori gastric cancer susceptibility gene-based testingDIAGNOSTIC_TEST

To establish an early diagnostic test system for gastric cancer based on the methylation site detection technology in feces, with or without the combination of Helicobacter pylori gastric cancer susceptibility gene detection, and then to evaluate the clinical diagnostic value of this test system.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age ≥ 18 years old, male or female not limited. * Within 90 days, the gastroscopy and/or pathological results confirm the absence of gastric cancer. * Patients must be able to fully understand the informed consent form and be able to personally sign it. Exclusion Criteria: * Severe cardiac, hepatic, or renal insufficiency, or psychiatric disorders. * A previous history of malignant tumors of the upper gastrointestinal tract. * Women during pregnancy. * Those with undefined pathology. * Those with unsatisfactory sample retention (e.g., too small a sample size)

Outcomes

Primary Outcomes

Sensitivity and specificity

Sensitivity and specificity of fecal DNA methylation detection and Helicobacter pylori gastric cancer susceptibility genes based on their application for early diagnosis and screening of gastric cancer.

Time frame: Baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.